MedTrace Logo

Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT02590107 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-05-15

No results posted yet for this study

Summary

This clinical trial studies the use of early oral supplementation in improving nutritional status in participants undergoing hematopoietic stem cell transplant. Impaired nutritional status in participants undergoing hematopoietic stem cell transplant has been linked to decreased outcomes such as increased length of hospital stay and increased time to engraftment (an important milestone in transplant recovery). Early oral supplementation may increase nutritional status and help to promote a positive outcome in participants undergoing transplant.

Conditions

  • Malignant Neoplasm

Interventions

DIETARY_SUPPLEMENT

Boost Plus

Receive nutritional supplementation twice daily to provide 28g of protein

DIETARY_SUPPLEMENT

Pro-Stat 101

Receive nutritional supplementation twice daily to provide 30g of protein

DIETARY_SUPPLEMENT

Milkshake

Receive alternate nutritional supplementation once daily to provide 28g protein

OTHER

daily food diaries

Participants will be given a food intake form, clipboard, and pen to record specific foods, as well as amounts of foods that are consumed from outside sources. In addition, the specific food items that each participant consumes will be recorded by the participant on his or her meal tickets which are included with each meal tray

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Autumn Diligente, MS, RDN, LD · Case Comprehensive Cancer Center

  • Stephanie Logosh, MS, RDN, LD · Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2018-03-01
Completion
2018-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02590107 on ClinicalTrials.gov